Page last updated: 2024-11-03

propranolol and Ear Neoplasms

propranolol has been researched along with Ear Neoplasms in 2 studies

Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.

Ear Neoplasms: Tumors or cancer of any part of the hearing and equilibrium system of the body (the EXTERNAL EAR, the MIDDLE EAR, and the INNER EAR).

Research Excerpts

ExcerptRelevanceReference
"In 2008, propranolol was serendipitously observed to cause accelerated involution of infantile haemangioma."7.77Low-dose propranolol for infantile haemangioma. ( Itinteang, T; Leadbitter, P; Tan, ST, 2011)
"In 2008, propranolol was serendipitously observed to cause accelerated involution of infantile haemangioma."3.77Low-dose propranolol for infantile haemangioma. ( Itinteang, T; Leadbitter, P; Tan, ST, 2011)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Salamat, AA1
Casselden, E1
Theaker, J1
Batty, V1
Thomas, S1
Tan, ST1
Itinteang, T1
Leadbitter, P1

Reviews

1 review available for propranolol and Ear Neoplasms

ArticleYear
Middle ear capillary haemangioma: Review of literature and appraisal of management options.
    Auris, nasus, larynx, 2016, Volume: 43, Issue:6

    Topics: Adrenergic beta-Antagonists; Child; Ear Neoplasms; Ear, Middle; Hemangioma, Capillary; Humans; Magne

2016

Other Studies

1 other study available for propranolol and Ear Neoplasms

ArticleYear
Low-dose propranolol for infantile haemangioma.
    Journal of plastic, reconstructive & aesthetic surgery : JPRAS, 2011, Volume: 64, Issue:3

    Topics: Administration, Oral; Adrenergic beta-Antagonists; Breast Neoplasms; Ear Neoplasms; Female; Follow-U

2011